Photo from wikipedia
Eumycetoma, a chronic subcutaneous mycosis, responds poorly to the available antifungal treatments and patients often require extensive surgical resection or amputation of the affected limb. More effective treatments are needed… Click to show full abstract
Eumycetoma, a chronic subcutaneous mycosis, responds poorly to the available antifungal treatments and patients often require extensive surgical resection or amputation of the affected limb. More effective treatments are needed for eumycetoma. This article will describe some of the approaches being used to develop and evaluate new treatments for eumycetoma, summarise the latest developments and discuss the challenges that lie ahead.
Keywords:
development novel;
novel antifungal;
update development;
antifungal agents;
agents eumycetoma
Journal Title: Frontiers in Pharmacology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Frontiers in Pharmacology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!